Headquarters
USA

Verge Genomics

Verge is developing therapies for neurological diseases with a unique all-in-human platform. Advances in data from patients are rapidly promoting the understanding of the biology of diseases of the central nervous system, allowing for the identification of disease targets. Verge de-risks these targets in patient-derived neurons in the laboratory to generate small molecules, creating a pipeline of potential therapeutics in early development for many diseases, including ALS and Parkinson's.

Visit the Verge Genomics website

Abonnez-vous aux mises à jour

Une mise à jour hebdomadaire de ce qui est à l'Agenda mondial

© 2021 World Economic Forum

Politique de confidentialité et conditions d’utilisation du service